Literature DB >> 17348633

Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells.

Joshua E Smith1, Colin D Medley, Zhiwen Tang, Dihua Shangguan, Charles Lofton, Weihong Tan.   

Abstract

We have extended the use the aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. The aptamers were selected using a cell-based SELEX strategy in our laboratory for cancer cells that, when utilized in this method, allow for the selective recognition of the cells from complex mixtures including fetal bovine serum samples. Aptamer-conjugated magnetic nanoparticles were used for the selective targeting cell extraction, and aptamer-conjugated fluorescent nanoparticles were employed for sensitive cellular detection. Employing both types of nanoparticles allows for selective and sensitive detection not possible by using the particles separately. Fluorescent nanoparticles amplify the signal intensity versus a single fluorophore label resulting in improved sensitivity. In addition, aptamer-conjugated magnetic nanoparticles allow for extraction and enrichment of target cells not possible with other separation methods. Fluorescent imaging and a microplate reader were used for cellular detection to demonstrate the wide applicability of this methodology for medical diagnostics and cell enrichment and separation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17348633     DOI: 10.1021/ac062151b

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  54 in total

1.  Development of DNA aptamers using Cell-SELEX.

Authors:  Kwame Sefah; Dihua Shangguan; Xiangling Xiong; Meghan B O'Donoghue; Weihong Tan
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

2.  Aptamer-based and DNAzyme-linked colorimetric detection of cancer cells.

Authors:  Xiaoli Zhu; Ya Cao; Zhiqiang Liang; Genxi Li
Journal:  Protein Cell       Date:  2010-10-07       Impact factor: 14.870

Review 3.  Molecular imaging with nucleic acid aptamers.

Authors:  H Hong; S Goel; Y Zhang; W Cai
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 4.  Recent developments in protein and cell-targeted aptamer selection and applications.

Authors:  Jun Liu; Mingxu You; Ying Pu; Huixia Liu; Mao Ye; Weihong Tan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 5.  Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.

Authors:  Alyssa B Chinen; Chenxia M Guan; Jennifer R Ferrer; Stacey N Barnaby; Timothy J Merkel; Chad A Mirkin
Journal:  Chem Rev       Date:  2015-08-27       Impact factor: 60.622

Review 6.  Drug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systems.

Authors:  Daniel J Sobczynski; Margaret B Fish; Catherine A Fromen; Mariana Carasco-Teja; Rhima M Coleman; Omolola Eniola-Adefeso
Journal:  Ther Deliv       Date:  2015-08-14

Review 7.  Aptamer-conjugated nanomaterials and their applications.

Authors:  Liu Yang; Xiaobing Zhang; Mao Ye; Jianhui Jiang; Ronghua Yang; Ting Fu; Yan Chen; Kemin Wang; Chen Liu; Weihong Tan
Journal:  Adv Drug Deliv Rev       Date:  2011-10-14       Impact factor: 15.470

Review 8.  Aptamers in immunotherapy.

Authors:  Claudia M Dollins; Smita Nair; Bruce A Sullenger
Journal:  Hum Gene Ther       Date:  2008-05       Impact factor: 5.695

Review 9.  Luminescent silica nanoparticles for cancer diagnosis.

Authors:  W Arap; R Pasqualini; M Montalti; L Petrizza; L Prodi; E Rampazzo; N Zaccheroni; S Marchiò
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

10.  Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells.

Authors:  Guodong Liu; Xun Mao; Joseph A Phillips; Hui Xu; Weihong Tan; Lingwen Zeng
Journal:  Anal Chem       Date:  2009-12-15       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.